Oseltamivir Capsule
Product Images NDC 42385-985

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Oseltamivir (NDC 42385-985). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laurus Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Oseltamivir Figure1)

Figure1 (Oseltamivir Figure1)
This text provides information about capsules containing oseltamivir phosphate USP, equivalent to 50 mg of oseltamivir. It includes general dosage instructions and important prescribing details. The capsules should be stored within a specific temperature range of 15° to 30°C (59° to 86°F). The text also mentions the manufacturer, PLAUrus Labs.*
FDA Label Image

Figure11 (Oseltamivir Figure11)

Figure11 (Oseltamivir Figure11)
Each capsule contains oseltamivir phosphate USP equivalent to 75 mg oseltamivir (free base). Usual dosage recommendations and important prescribing information are provided. Store at 20° to 26°C (68° to 77°F). Excursions permitted between 15° and 30°C (59° to 86°F). This product is available in 100 capsules and is for prescription use only.*
FDA Label Image

Figure12 (Oseltamivir Figure12)

FDA Label Image

Figure13 (Oseltamivir Figure13)

FDA Label Image

Figure16 (Oseltamivir Figure16)

Figure16 (Oseltamivir Figure16)
This text describes various symptoms related to allergic reactions or skin conditions, including skin rash, hives, blistering, peeling skin, blisters or sores in the mouth, itching, swelling of the face, eyes, lips, tongue, or throat, trouble breathing, and chest pain or tightness. These symptoms may indicate a serious allergic reaction or a skin condition that requires medical attention.*
FDA Label Image

Figure2 (Oseltamivir Figure2)

Figure2 (Oseltamivir Figure2)
This document appears to contain details about various Oseltamivir Phosphate capsules. It includes information such as National Drug Codes (NDC), manufacturer details (Laurus Labs Limited), lot numbers, and expiration dates. The capsules seem to come in strengths of 30mg and are for prescription use only.*
FDA Label Image

Figure3 (Oseltamivir Figure3)

FDA Label Image

Figure6 (Oseltamivir Figure6)

Figure6 (Oseltamivir Figure6)
Each capsule contains oseltamivir phosphate USP equivalent to 45 mg oseltamivir (free base). The usual dosage is outlined in the accompanying insert. Store between 20° to 25°C (68° to 77°F), with excursions allowed between 15° and 30°C (59° to 86°F). This medication is produced by Laurus Generics Inc., with manufacturing details provided. It is recommended for prescription use.*
FDA Label Image

Figure7 (Oseltamivir Figure7)

FDA Label Image

Figure8 (Oseltamivir Figure8)

Figure8 (Oseltamivir Figure8)
This is a description of Oseltamivir Phosphate capsules, each containing 45 mg of oseltamir (free base). The capsules come in a pack of 10 unit-dose capsules for prescription use only. The usual storage conditions are between 20-25°C (68-77°F), with permissible excursions between 15-30°C (59-86°F). The medication is manufactured by Laurus Labs Limited. For dosage recommendations and prescribing information, refer to the accompanying insert.*
FDA Label Image

Oseltamivir-structure (Oseltamivir Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.